Literature DB >> 1320344

Persistence of eggs and hepatic fibrosis after treatment of Schistosoma mansoni-infected mice.

A W Cheever1, J G Macedonia, S Deb, E A Cheever, J E Mosimann.   

Abstract

In 1971 we estimated that Schistosoma mansoni eggs in the tissues of mice were destroyed with an approximate half-life of four weeks. Our present results of five experiments suggest that egg destruction is not as rapid, and no significant destruction of eggs was detected for up to 26 weeks after treatment. However, in these experiments, a mean of 60% of the eggs in intestinal tissues were found in the feces at the time of treatment. In previously reported experiments, only 15% of gut eggs were passed in the feces. We now believe that underestimation of the number of eggs passed in the feces led to an overestimation of the number of eggs destroyed in the tissues. We analyzed liver eggs separately because eggs lost from this site are unaffected by eggs passed in the feces. No significant decrease in liver eggs occurred in the present experiments, but reanalysis of previously published data showed significant egg destruction in the liver in several experiments, although at a much slower rate than previously estimated. However, inspection of the data in the previously published and present experiments does not show a convincing difference in the number of eggs in the liver after treatment. The persistence of egg shells is probably not important in the pathogenesis of disease, but is of concern in calculating worm fecundity. Hepatic collagen levels increased markedly two weeks after treatment and subsequently decreased significantly in some, but not all, experiments.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320344     DOI: 10.4269/ajtmh.1992.46.752

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

1.  Parasitological evaluation of Ro 15-9268, a 9-acridanone-hydrazone derivative against Schistosoma mansoni in mice, and observations on changes in serum enzyme levels.

Authors:  Sayed Rawi; Osama Abdel-Ghaffar Youssef; Aisha Metwally; Mohamed Badawy; Mansour Al-Hazmi
Journal:  Parasitol Res       Date:  2013-11-22       Impact factor: 2.289

2.  Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis.

Authors:  Jie Luo; Yuejin Liang; Fanping Kong; Jingfan Qiu; Xinjian Liu; Ailing Chen; Bruce A Luxon; Hannah W Wu; Yong Wang
Journal:  Immunol Cell Biol       Date:  2016-11-03       Impact factor: 5.126

3.  Chronic hepatitis in experimental schistosomiasis.

Authors:  Z A Andrade; A W Cheever
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  The sex lives of parasites: investigating the mating system and mechanisms of sexual selection of the human pathogen Schistosoma mansoni.

Authors:  Michelle L Steinauer
Journal:  Int J Parasitol       Date:  2009-03-17       Impact factor: 3.981

5.  Confocal laser scanning microscopy for detection of Schistosoma mansoni eggs in the gut of mice.

Authors:  Martha Charlotte Holtfreter; Oliver Stachs; Maria Reichard; Micha Loebermann; Rudolf Friedrich Guthoff; Emil Christian Reisinger
Journal:  PLoS One       Date:  2011-04-18       Impact factor: 3.240

6.  Microarray assessment of N-glycan-specific IgE and IgG profiles associated with Schistosoma mansoni infection in rural and urban Uganda.

Authors:  Gyaviira Nkurunungi; Angela van Diepen; Jacent Nassuuna; Richard E Sanya; Margaret Nampijja; Irene Nambuya; Joyce Kabagenyi; Sonia Serna; Niels-Christian Reichardt; Ronald van Ree; Emily L Webb; Alison M Elliott; Maria Yazdanbakhsh; Cornelis H Hokke
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

Review 7.  Praziquantel treatment in trematode and cestode infections: an update.

Authors:  Jong-Yil Chai
Journal:  Infect Chemother       Date:  2013-03-29

8.  The Effect of Helminth Infections and Their Treatment on Metabolic Outcomes: Results of a Cluster-Randomized Trial.

Authors:  Richard E Sanya; Emily L Webb; Christopher Zziwa; Robert Kizindo; Moses Sewankambo; Josephine Tumusiime; Esther Nakazibwe; Gloria Oduru; Emmanuel Niwagaba; Prossy Kabuubi Nakawungu; Joyce Kabagenyi; Jacent Nassuuna; Bridgious Walusimbi; Irene Andia-Biraro; Alison M Elliott
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.